The federal government will rely heavily on commercial labs to run the vast majority of coronavirus tests. Those labs, along with hospitals and academic institutions, could bill patients and their insurance companies for testing.
How much each patient pays will ultimately depend on whether they have insurance, what kind of plan they have and whether it requires cost-sharing, like deductibles and copays. Continue reading.